← Open Payments lookup

KATHRYN BYCURA: Open Payments

NPI 1235427238 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300 in 16 payments from 8 companies in 2025. Trend: 2023 $678 · 2024 $780 · 2025 $300

Food & beverage: $300
CompanyPaymentsAmount
ABBVIE INC.6$112
Regeneron Healthcare Solutions, Inc.1$36
Janssen Biotech, Inc.2$33
Phathom Pharmaceuticals, Inc.3$33
Lilly USA, LLC1$24
Gilead Sciences, Inc.1$23
Celltrion USA Inc.1$21
Takeda Pharmaceuticals U.S.A., Inc.1$17

Products named: RINVOQ, DUPIXENT, TREMFYA, VOQUEZNA, OMVOH, LINZESS, CREON, VEGZELMA.

Industry payments across LA — which companies pay providers there.